Effect of the Coughing Technique During Subcutaneous Heparin Injection

Inguinal Hernia Clinical Trial

Official title:

Effect of the Coughing Technique During Subcutaneous Heparin Injection on Pain Severity and Individual Satisfaction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05681338
• Other study ID #: 2022-6/18
• Status: Completed
• Phase: N/A
• Start date: March 17, 2022
• Est. completion date: June 30, 2022

Study information

• Verified date: January 2023
• Source: Uludag University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Objective: to examine the effect of the medium intensity coughing technique during subcutaneous low molecular weight heparin injection on pain severity and individual satisfaction in general surgery patients. Method: a prospective, quasi-experimental study included 100 patients who had prescribed a subcutaneous low molecular weight heparin injection once in 24 hours. Each patient received two injections by the same researcher using standard injection technique with medium intensity coughing technique and only standard injection technique.

Description:

Aims and objectives: The aim of this study was to examine the effect on the level of pain severity and satisfaction of patients of the medium intensity coughing technique applied to patients during the administration of subcutaneous low molecular weight heparin (LMWH) injection.

Design: This research was a prospective quasi-experimental study. Methods: It was conducted with 100 patients in the General Surgery Clinic of a university hospital in the Marmara Region of Turkey. Subcutaneous LMWH injections were administered by the same nurse to the outer side of the right and left upper arms by the standard injection technique and the medium intensity coughing technique. Immediately after the subcutaneous LMWH injection was given, a researcher who did not know which injection method had been used asked the patients to evaluate their pain levels by the Visual Analog Scale (VAS) and their satisfaction with the performance of the injection by the Visual Individual Satisfaction Scale (VISS).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: June 30, 2022
• Est. primary completion date: May 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 22 Years to 86 Years

Eligibility

Inclusion Criteria:

• Participating voluntarily in the study

• Being over the age of 18,

• Having a doctor's prescription for subcutaneous low molecular weight heparin 0.6 mL treatment and not yet having begun treatment.

• Having no coagulation disorder, having no disorder that could affect pain perception, -

• Having no incision, lipodystrophy, or finding of infection at the injection site,

• Having no communication problem

Exclusion Criteria:

• Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study

• Having any condition which would affect the sensation of pain

• Not being able to agree on a place or time

• Being less than 18 years of age

Related Conditions & MeSH terms

• Cholecystectomy
• Colon Surgery
• Cough
• Hernia, Inguinal
• Inguinal Hernia
• Thyroidectomy

Intervention

Other:
• the medium intensity coughing technique
The medium intensity coughing technique: Immediately before the subcutaneous LMWH injection was given, patients were asked to cough twice at a medium level. After that, they were asked to cough ten seconds later for a second time at the same level, and while they were coughing for the second time, the needle was inserted into the tissue.

Locations

Country	Name	City	State
Turkey	Bursa Uludag University Hospital	Bursa	Nilüfer

Sponsors (1)

Lead Sponsor	Collaborator
Uludag University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain assessed by Visual Analog Scale (VAS)	In evaluating the severity of pain felt by the patients during subcutaneous injections, a 10 cm long vertical VAS was used, on which one end represented no pain, and the other end the worst possible pain. The VAS is a commonly used pain assessment scale in clinical settings. Pain severity measurements were evaluated in millimeters.	2 months
Primary	"Satisfaction assessed by the Visual Individual Satisfaction Scale (VISS)	During the administration of the injection, an evaluation was made to determine individuals' satisfaction using the Visual Individual Satisfaction Scale, which consisted of a vertical 10 cm scale with "I'm very satisfied" written at one end of it and "I'm not at all satisfied" at the other. The Visual Individual Satisfaction Scale incorporated the characteristics of the well-known Visual Analog Scale (VAS). Satisfaction level measurements were evaluated in millimeters.	2 months
Secondary	Weight	weight in kilograms	2 months
Secondary	Height	height in meters	2 months
Secondary	BMI	BMI in kg/m^2	2 months